About the Company
We do not have any company description for SURMODICS INC at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
355
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on SURMODICS INC
Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare ...
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts
Surmodics, Inc. SRDX delivered adjusted earnings per share (EPS) of 6 cents in the third quarter of fiscal 2025 against the ...
Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that third quarter of fiscal year 2025 financial ...
SurModics: Fiscal Q3 Earnings Snapshot
SurModics Inc. (SRDX) on Friday reported a loss of $5.3 million in its fiscal third quarter. On a per-share basis, the Eden ...
Surmodics Enters into Definitive Agreement to be Acquired by GTCR for ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that it ...
Surmodics, Inc. (NASDAQ:SRDX) up 11%, but insiders miss out having sold ...
While it’s been a great week for Surmodics, Inc. (NASDAQ:SRDX) shareholders after stock gained 11%, company insiders might have missed out on those gains after selling stock earlier this year ...
Second Time May Be a Charm: Analyst Is Bullish As Surmodics ... - Benzinga
In an investor presentation, Surmodics Inc SRDX said it submitted its amended SurVeil drug-coated balloon premarket approval (PMA) application in May – with no new testing required.
Surmodics Reports Fourth Quarter and Fiscal Year 2023 Financial Results ...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today reported f ...
Surmodics (SRDX) Stock Loses 2.2% Despite Q4 Earnings Beat
Shares of Surmodics, Inc. SRDX declined 2.2% on Nov 11, following the company's fiscal fourth-quarter 2021 results.The company reported fourth-quarter fiscal 2021 adjusted loss per share of 10 ...
CEO resigning from SurModics
Eden Prairie-based SurModics, Inc., a leading provider of drug delivery and surface modification technologies to the health care industry, has announced that Bruce J. Barclay is resigning as ...
Similar Companies
Loading the latest forecasts...